Persistence of Mild to Moderate Atopic Dermatitis

作者: Jacob S. Margolis , Katrina Abuabara , Warren Bilker , Ole Hoffstad , David J. Margolis

DOI: 10.1001/JAMADERMATOL.2013.10271

关键词: Prospective cohort studyObservational studySeverity of illnessMedicineYoung adultPediatricsMEDLINECohort studyNatural historyAtopic dermatitis

摘要: Importance Atopic dermatitis (AD) is a common illness of childhood. Objective To evaluate the natural history AD and determine persistence symptoms over time. Design, Setting, Participants A cross-sectional cohort study nation-wide long-term registry children with enrolled in Pediatric Eczema Elective Registry (PEER). Main Outcomes Measures Self-reported outcome whether child’s skin was symptom–free for 6 months at 6-month intervals. Results total 7157 patients were PEER 22 550 person-years. At least 2 years follow-up observed 4248 5 2416 children. Multiple demographic exposure variables associated more persistent AD. every age (ie, 2-26 years), than 80% participants had and/or using medication to treat their It not until 20 that 50% 1 lifetime symptom- treatment-free period. Conclusions Relevance Based on this large longitudinal study, seem persist well into second decade life likely longer. probably life-long illness.

参考文章(26)
Hoare, Li Wan Po, Williams, Systematic review of treatments for atopic eczema Health Technology Assessment. ,vol. 4, pp. 1- 191 ,(2000) , 10.3310/HTA4370
Jon M Hanifin, Kevin D Cooper, Vincent C Ho, Sewon Kang, Bernice R Krafchik, David J Margolis, Lawrence A Schachner, Robert Sidbury, Susan E Whitmore, Carol K Sieck, Abby S Van Voorhees, Guidelines of care for atopic dermatitis Journal of The American Academy of Dermatology. ,vol. 50, pp. 391- 404 ,(2004) , 10.1016/J.JAAD.2003.08.003
David J. Margolis, Andrea J. Apter, Jayanta Gupta, Ole Hoffstad, Maryte Papadopoulos, Linda E. Campbell, Aileen Sandilands, W.H. Irwin McLean, Tim R. Rebbeck, Nandita Mitra, The persistence of atopic dermatitis and filaggrin (FLG) mutations in a US longitudinal cohort. The Journal of Allergy and Clinical Immunology. ,vol. 130, pp. 912- 917 ,(2012) , 10.1016/J.JACI.2012.07.008
Brunello Wüthrich, Clinical aspects, epidemiology, and prognosis of atopic dermatitis Annals of Allergy Asthma & Immunology. ,vol. 83, pp. 464- 470 ,(1999) , 10.1016/S1081-1206(10)62852-9
Hywel Williams, Colin Robertson, Alistair Stewart, Nadia Aït-Khaled, Gabriel Anabwani, Ross Anderson, Innes Asher, Richard Beasley, Bengt Björkstén, Michael Burr, Tadd Clayton, Julian Crane, Philippa Ellwood, Ulrich Keil, Chris Lai, Javier Mallol, Fernando Martinez, Edwin Mitchell, Stephen Montefort, Neil Pearce, Jayant Shah, Bonnie Sibbald, David Strachan, Erika von Mutius, Stephan K. Weiland, Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. The Journal of Allergy and Clinical Immunology. ,vol. 103, pp. 125- 138 ,(1999) , 10.1016/S0091-6749(99)70536-1
Eric L. Simpson, Laura E. Keck, Joanne R. Chalmers, Hywel C. Williams, How should an incident case of atopic dermatitis be defined? A systematic review of primary prevention studies The Journal of Allergy and Clinical Immunology. ,vol. 130, pp. 137- 144 ,(2012) , 10.1016/J.JACI.2012.01.075
Angela S. W. Tjon, Jerome Sint Nicolaas, Jaap Kwekkeboom, Robert A. de Man, Geert Kazemier, Hugo W. Tilanus, Bettina E. Hansen, Luc J. W. van der Laan, Thanyalak Tha-In, Herold J. Metselaar, Increased incidence of early de novo cancer in liver graft recipients treated with cyclosporine: An association with C2 monitoring and recipient age Liver Transplantation. ,vol. 16, pp. 837- 846 ,(2010) , 10.1002/LT.22064
Nadja Hawwa Vissing, Signe Marie Jensen, Hans Bisgaard, Validity of information on atopic disease and other illness in young children reported by parents in a prospective birth cohort study BMC Medical Research Methodology. ,vol. 12, pp. 160- 160 ,(2012) , 10.1186/1471-2288-12-160
Sara J. Brown, W.H. Irwin McLean, One remarkable molecule: Filaggrin Journal of Investigative Dermatology. ,vol. 132, pp. 751- 762 ,(2012) , 10.1038/JID.2011.393
Lawrence F. Eichenfield, Anne W. Lucky, Mark Boguniewiczc, Richard G.B. Langley, Robert Cherille, Katharine Marshalle, Christopher Bushe, Michael Graeber, Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents. Journal of The American Academy of Dermatology. ,vol. 46, pp. 495- 504 ,(2002) , 10.1067/MJD.2002.122187